Keros Therapeutics, Inc. (KROS)

CIK 1664710 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Keros Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 202610-Q0001664710-26-000066
Nov 5, 20268-K0001664710-26-000067
Nov 5, 20268-K0001664710-26-000065
Oct 27, 2026SCHEDULE 13G/A0002052113-26-001128
Sep 29, 20268-K0001664710-26-000059
Sep 28, 20268-K0001664710-26-000056
Sep 16, 2026EFFECT9999999995-26-002985
Sep 11, 2026DEL AM0001628280-26-061536
Sep 10, 2026S-30001628280-26-061321
Sep 8, 20268-K0001664710-26-000053
Aug 20, 202640001866219-26-000010
Aug 20, 202640002081460-26-000009
Aug 20, 202640002081359-26-000008
Aug 20, 202640002146784-26-000004
Aug 19, 202640001221590-26-000025
Aug 18, 20261440001969223-26-000924
Aug 13, 202630002146784-26-000002
Aug 3, 20268-K0001664710-26-000048
Aug 3, 202610-Q0001664710-26-000049
Aug 3, 20268-K0001664710-26-000050
Jul 30, 20268-K0001664710-26-000043
Jul 29, 2026SCHEDULE 13G/A0002012383-26-002890
Jul 22, 20268-K0001664710-26-000038
Jul 17, 202640001221590-26-000023
Jul 17, 2026SCHEDULE 13G0002052113-26-000752